Steven Cohen Amgen Inc Put Options Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $46.1 Million - $51.3 Million	-200,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $43.9 Million - $48.5 Million	200,000 New	200,000 $48.4 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $15.3 Million - $17.9 Million	-86,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $15.9 Million - $18 Million	86,000 New	86,000 $17.8 Million

2,936

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.